Sfoglia per Afferenza DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Cellular and molecular characterization of the infiltrating polarized macrophages during the onset of heterotopic ossification in a mouse model of Fibrodysplasia Ossificans Progressiva (FOP).
2024 Gamberale, R
Meta-problems in global optimization: new perspectives from Computational Intelligence
2024 Papetti, D
Immune response to SARS-CoV-2 natural infection and vaccination in healthy subjects and in immunocompromised patients
2024 Favalli, A
Transcriptional and epigenetic regulation of immune cells mediated by transposable elements in human health and cancer
2024 Polimeni, B
Single-Cell RNA Sequencing and Bisulfite Sequencing: Unveiling the Complexity of Dendritic Cell Heterogeneity and DNA Methylation Dynamics
2024 Protti, G
Study of the immunological landscape in Myelodysplastic Syndromes: a multi-omics approach
2024 Riva, E
UNVEILING THE CHROMATIN ORGANIZATION MEDIATED BY LINE1 ELEMENTS IN HUMAN T CELL QUIESCENCE
2024 Salviati, L
Neuropsychological profile of chronic pain: implications for diagnosis and treatments
2024 Telesca, A
Identification of imaging biomarkers for neurodegenerative disorders: a comparative pre-clinical study in selected animal models
2024 TASSAN MAZZOCCO, M
AIR POLLUTION NANOPARTICLES AND DOUBLE-FUNCTIONALIZED LIPOSOMES: THE CULPRITS AND RESCUERS OF THE IMPAIRED NEURONAL SYNAPTIC FUNCTION
2024 DI GIROLAMO, S
Investigating the role of large microglial extracellular vesicles in Alzheimer’s disease and their interaction with neurons
2024 Battocchio, E
Mitochondrial dysfunction and neuroinflammation in Parkinson’s disease models: the protective effect of Nerve Growth Factor (NGF)
2024 Goglia, I
Modeling target treatment of high-risk childhood Acute Lymphoblastic Leukemia (ALL)
2024 Oikonomou, A
Development and characterization of a novel therapeutic bispecific antibody targeting BCMA and PDL1 for the treatment of multiple myeloma.
2024 Cattaneo, I
Genome editing strategy to treat Severe Combined Immunodeficiency due to Recombination Activating Gene 1 (RAG1) defects
2024 Brandas, C
Characterizing Molecular Pathways and Therapeutic Prospects in MDS/MPN Neoplasms: A Focus on SETBP1 Mutations
2024 Crippa, V
Iron as nutrient and potential toxic element in different pathological disorders
2024 Capelletti, M
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia
2024 Raggi, L
The "Preeclampsia and Hypertension Target Treatment" ("PYTT") study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings
2024 Pasquo, E; Giannubilo, S; Valentini, B; Salvi, S; Rullo, R; Fruci, S; Filippi, E; Ornaghi, S; Zullino, S; Rossi, F; Farsetti, D; Martino, D; Vasapollo, B; Locatelli, A; De Santis, M; Ciavattini, A; Lanzone, A; Mecacci, F; Ferrazzi, E; Valensise, H; Ghi, T
Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Kjeldsen, S; Muiesan, M; Thomopoulos, C; Tsioufis, K; Kreutz, R
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile